|
As China's leading journal in pharmacology, APS offers high-quality, independently peer-reviewed research and review articles. Featured topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.
APS now offers authors the option for immediate open access publication. NPG will deposit published open access papers in PubMed Central at the time of publication. Find out more from our FAQs page.
With an impact factor of 1.953* this journal brings cutting-edge research to an international readership.
|
